Rohan Dharmakumar
Clinical trials sponsored by Rohan Dharmakumar, explained in plain language.
-
Could a single drug infusion limit permanent heart damage during a heart attack?
Disease control CompletedThis study tested whether a drug called dexrazoxane, given through a vein, can reduce permanent heart muscle damage in people having a severe heart attack (STEMI). Fifty adults received either the drug or a placebo during their standard stent procedure. The goal was to see if the…
Phase: PHASE2 • Sponsor: Rohan Dharmakumar • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Blood test may replace scans for heart attack staging
Diagnosis CompletedThis study looked at whether a high-sensitivity blood test for troponin I can accurately determine the stage of a heart attack. Researchers analyzed data from 312 patients across multiple hospitals. The goal is to provide a faster, simpler way to classify heart attack severity wi…
Sponsor: Rohan Dharmakumar • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
Simple blood test may spot hidden bleeding in heart attacks
Diagnosis CompletedThis pilot study tested whether a common blood test for troponin, a heart damage marker, can tell if a heart attack involves bleeding in the heart muscle. Researchers measured troponin levels in 227 patients after they had a heart attack and compared those with and without bleedi…
Sponsor: Rohan Dharmakumar • Aim: Diagnosis
Last updated Jun 26, 2026 15:17 UTC
-
Heart attack bleeding linked to dangerous rhythms after stent procedure
Knowledge-focused CompletedThis completed study looked at 250 adults who had a severe type of heart attack (STEMI) treated with a stent. Researchers used portable heart monitors to check how often dangerous heart rhythms occurred in people whose heart attack involved bleeding. The goal was to better unders…
Sponsor: Rohan Dharmakumar • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Heart attack drug safety under scrutiny: new study examines bleeding risks
Knowledge-focused CompletedThis completed study looked at over 6,000 heart attack patients to see how different antiplatelet medications affect the risk of bleeding inside the heart. Researchers compared outcomes like heart-related events, bleeding complications, and death within 30 days. The goal is to he…
Sponsor: Rohan Dharmakumar • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New heart scan may predict deadly rupture after heart attack
Knowledge-focused CompletedThis study looked at 250 people who had a severe type of heart attack involving bleeding into the heart muscle. Researchers tested whether a measurement called the wall strain index ratio, taken from a heart MRI, could identify areas of the heart at risk of tearing (rupture). The…
Sponsor: Rohan Dharmakumar • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Can a simple score predict a dangerous type of heart attack?
Knowledge-focused CompletedResearchers have created a prediction score to estimate the chance of a hemorrhagic (bleeding) heart attack in patients before they undergo emergency artery-opening treatment. The study involved 252 adults having their first heart attack and treated with primary PCI. The goal is …
Sponsor: Rohan Dharmakumar • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Massive US study reveals hidden bleeding complication after heart attacks
Knowledge-focused CompletedThis completed study looked at medical records from over 24,000 people across the United States who had a heart attack. The goal was to find out how often a specific complication called hemorrhagic myocardial infarction (bleeding inside the heart muscle) occurs. Researchers also …
Sponsor: Rohan Dharmakumar • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:28 UTC